How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?

Part of paid clinical trials in Duluth, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT07457372
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Vagus Nerve Stimulation

Eligibility Criteria

Sex
ALL
Age
18 Years - 35 Years
Healthy Volunteers
Accepted

Interventions

  • Active taVNS — DEVICE
    Actual taVNS
  • Sham taVNS — DEVICE
    No nerve stimulation

Study Details

The purpose of this study is to determine the feasibility of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to examine physiological and psychological responses in a college-aged healthy population

Key Dates

Start date
Jul 1, 2026
Status verified
May 2026
Primary completion
May 1, 2028
Completion
May 1, 2028

Study Design

Enrollment
8 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE

Arms

  • Active Comparator: Active taVNS
  • Placebo Comparator: Sham taVNS

Primary Outcome Measure

Change in plasma glucose [ Time Frame: Hour 2 after oral glucose load ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Minnesota DuluthDuluthMinnesota55812
Mark Hartman, PhD
218-726-7275

Find similar trials in Duluth, MN

Related Studies